Successful Life Science Collaborations Require Flexibility
February 21, 2013, 11:57 AM EST
Law360, New York (February 21, 2013, 11:57 AM EST) -- It goes without saying that the process of getting innovative new medicines to patients is a long, complex and expensive undertaking. One of the ironies of the life sciences industry, however, is that small companies — the ones that don’t always have the time, money or global capabilities to develop and launch a new medicine on its own — are the source of much of the innovation in it.
Strategic partnering, therefore, is important. For emerging companies, it can provide capital, expertise and global reach that...